Get started
AMGEN DRNAMGEN DRNAMGEN DRN

AMGEN DRN

No trades
See on Supercharts
Overview
Financials News Ideas Technicals

AMGN34 chart

Key stats

Market capitalization
‪741.51 B‬BRL
Dividend yield (indicated)
2.16%
Price to earnings Ratio (TTM)
22250.00
Basic EPS (TTM)
0.00BRL
Net income
‪33.55 B‬BRL
Revenue
‪139.91 B‬BRL
Shares float
—
Beta (1Y)
−0.10

About AMGEN DRN

Sector
Health Technology
CEO
Robert A. Bradway
Headquarters
Thousand Oaks
Website
amgen.com
Employees (FY)
‪26.7 K‬
Founded
1980
ISIN
BRAMGNBDR004
FIGI
BBG002H1H201
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Sparks

Curated watchlists where AMGN34 is featured.

See all sparks